Eagle Pharmaceuticals, Inc. Long-Term Debt
Eagle Pharmaceuticals, Inc. had Long-Term Debt of $61.90 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2023-08-09
- 2023-06-30: Long-term Debt, Excluding Current Maturities $61.90M.
- 2023-03-31: Long-term Debt, Excluding Current Maturities $68.83M.
- 2022-12-31: Long-term Debt, Excluding Current Maturities $56.22M.
- 2022-09-30: Long-term Debt, Excluding Current Maturities $26.43M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2023-06-30 | $61.90M 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $68.83M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $56.22M 10-Q/A · filed 2023-08-09 |
| 2022-09-30 | $26.43M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $28.02M 10-Q · filed 2022-08-09 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-23 |
| 2021-09-30 | $19.49M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $21.37M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $23.25M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $25.14M 10-K · filed 2022-03-08 |
| 2020-09-30 | $27.02M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $28.90M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $30.78M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $33.56M 10-K · filed 2021-03-05 |
| 2019-09-30 | $35.69M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $35.84M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $37.00M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $38.16M 10-K · filed 2020-03-02 |
| 2018-09-30 | $39.31M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $40.47M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $41.62M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $42.91M 10-K · filed 2019-02-28 |
| 2017-09-30 | $43.94M 10-Q · filed 2017-11-08 |
| 2016-12-31 | $0.00 10-K · filed 2018-02-26 |